ikapress 180 mg
teva pharmaceutical industries ltd, israel - verapamil hydrochloride - tablets sustained release - verapamil hydrochloride 180 mg - verapamil - verapamil - mild to moderate hypertention. angina pectoris.
mylan-verapamil sr tablet (extended-release)
mylan pharmaceuticals ulc - verapamil hydrochloride - tablet (extended-release) - 120mg - verapamil hydrochloride 120mg - miscellaneous calcium-channel blocking agents
ikacor 40 mg
teva pharmaceutical industries ltd, israel - verapamil hydrochloride - tablets - verapamil hydrochloride 40 mg - verapamil - verapamil - angina pectoris, cardiac arrhythmias, hypertension.
ikacor 120 mg
teva pharmaceutical industries ltd, israel - verapamil hydrochloride - tablets - verapamil hydrochloride 120 mg - verapamil - verapamil - angina pectoris, cardiac arrhythmias, hypertension.
mylan-verapamil tablet
mylan pharmaceuticals ulc - verapamil hydrochloride - tablet - 80mg - verapamil hydrochloride 80mg - miscellaneous calcium-channel blocking agents
mylan-verapamil tablet
mylan pharmaceuticals ulc - verapamil hydrochloride - tablet - 120mg - verapamil hydrochloride 120mg - miscellaneous calcium-channel blocking agents
verapamil sr tablet (extended-release)
sorres pharma inc - verapamil hydrochloride - tablet (extended-release) - 240mg - verapamil hydrochloride 240mg - miscellaneous calcium-channel blocking agents
verapamil hydrochloride tablet, extended release
aphena pharma solutions - tennessee, llc - verapamil hydrochloride (unii: v3888oey5r) (verapamil - unii:cj0o37ku29) - verapamil hydrochloride 180 mg - verapamil hydrochloride extended-release tablets are indicated for the treatment of hypertension, to lower blood pressure. lowering blood pressure reduces the risk of fatal and nonfatal cardiovascular events, primarily strokes and myocardial infarctions. these benefits have been seen in controlled trials of antihypertensive drugs from a wide variety of pharmacologic classes including this drug. control of high blood pressure should be part of comprehensive cardiovascular risk management, including, as appropriate, lipid control, diabetes management, antithrombotic therapy, smoking cessation, exercise, and limited sodium intake. many patients will require more than one drug to achieve blood pressure goals. for specific advice on goals and management, see published guidelines, such as those of the national high blood pressure education program’s joint national committee on prevention, detection, evaluation, and treatment of high blood pressure (jnc). numerous antihypertensive drugs, from a variety of ph
verapamil hydrochloride tablet, extended release
sun pharmaceutical industries, inc. - verapamil hydrochloride (unii: v3888oey5r) (verapamil - unii:cj0o37ku29) - verapamil hydrochloride 120 mg - verapamil hydrochloride extended-release tablets are indicated for the treatment of hypertension, to lower blood pressure. lowering blood pressure reduces the risk of fatal and nonfatal cardiovascular events, primarily strokes and myocardial infarctions. these benefits have been seen in controlled trials of antihypertensive drugs from a wide variety of pharmacologic classes including this drug. control of high blood pressure should be part of comprehensive cardiovascular risk management, including, as appropriate, lipid control, diabetes management, antithrombotic therapy, smoking cessation, exercise, and limited sodium intake. many patients will require more than one drug to achieve blood pressure goals. for specific advice on goals and management, see published guidelines, such as those of the national high blood pressure education program’s joint national committee on prevention, detection, evaluation, and treatment of high blood pressure (jnc). numerous antihypertensive drugs, from a variety of ph
verapamil hydrochloride- verapamil hydrochloride tablet, film coated, extended release
unit dose services - verapamil hydrochloride (unii: v3888oey5r) (verapamil - unii:cj0o37ku29) - verapamil hydrochloride 240 mg - verapamil hydrochloride extended-release tablets usp are indicated for the treatment of hypertension, to lower blood pressure. lowering blood pressure reduces the risk of fatal and nonfatal cardiovascular events, primarily strokes and myocardial infarctions. these benefits have been seen in controlled trials of antihypertensive drugs from a wide variety of pharmacologic classes including this drug. control of high blood pressure should be part of comprehensive cardiovascular risk management, including, as appropriate, lipid control, diabetes management, antithrombotic therapy, smoking cessation, exercise, and limited sodium intake. many patients will require more than one drug to achieve blood pressure goals. for specific advice on goals and management, see published guidelines, such as those of the national high blood pressure education program’s joint national committee on prevention, detection, evaluation, and treatment of high blood pressure (jnc). numerous antihypertensive drugs, from a variety of pharma